Aurobindo, Hetero, and Vivimed Class Action Settlements in Ohio
Aurobindo, Hetero, and Vivimed class action settlements that covered Ohio residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Ohio residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Ohio Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Ohio
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Ohio residents affected by contaminated blood pressure medications from manufacturers Aurobindo, Hetero, and Vivimed have legal recourse through class action settlements, particularly the $15.2 million settlement covering Valsartan, Losartan, and Irbesartan medications. Ohio's Consumer Sales Practices Act provides additional protections beyond federal regulations, allowing residents to pursue claims for deceptive trade practices related to contaminated pharmaceuticals. These manufacturers maintain significant distribution networks serving Ohio's major healthcare systems, including Cleveland Clinic and Ohio State University Wexner Medical Center, where thousands of patients received the affected medications. Ohio follows federal class action procedures under Rule 23, but residents must be aware of Ohio's two-year statute of limitations for personal injury claims related to defective products. The state's Attorney General has actively monitored pharmaceutical settlements affecting Ohioans, ensuring proper notice reaches affected residents. Ohio residents can file claims individually or participate in certified class actions, with compensation potentially available for medical monitoring, out-of-pocket expenses, and in severe cases involving cancer diagnoses linked to NDMA contamination, additional damages for pain and suffering.
Aurobindo, Hetero, and Vivimed Settlements in Ohio: FAQs
How does Ohio's Consumer Sales Practices Act affect my Aurobindo, Hetero, or Vivimed claim?
Ohio's Consumer Sales Practices Act allows you to seek additional damages beyond the federal class action settlement if these manufacturers engaged in deceptive practices. This could include attorney fees and punitive damages not available in the $15.2M settlement for contaminated blood pressure medications.
Which Ohio hospitals and pharmacies distributed contaminated Aurobindo, Hetero, and Vivimed medications?
Major Ohio healthcare systems including Cleveland Clinic, Ohio State University Wexner Medical Center, and Kroger pharmacies statewide distributed these contaminated medications. You should check your pharmacy records from 2018-2020 to determine if you received affected Valsartan, Losartan, or Irbesartan products.
What is the deadline for Ohio residents to file claims against Aurobindo, Hetero, and Vivimed?
Ohio follows a two-year statute of limitations for defective product claims, but class action settlement deadlines may differ. For the $15.2M Valsartan settlement, check the specific claim filing deadline as it may be shorter than Ohio's general statute of limitations.
Tips for Ohio Residents Filing Aurobindo, Hetero, and Vivimed Claims
Ohio residents filing Aurobindo, Hetero, and Vivimed claims should gather all prescription records from 2018-2020, focusing on Valsartan, Losartan, and Irbesartan medications. Contact your pharmacy for detailed medication lot numbers and manufacturer information. Document any medical expenses related to cancer screenings or treatments potentially linked to NDMA contamination. Consider consulting Ohio attorneys experienced with pharmaceutical class actions, as they understand state-specific consumer protection laws that may provide additional remedies beyond federal settlements. File claims promptly, as Ohio's two-year statute of limitations and settlement deadlines create strict timeframes for pursuing compensation.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
